Effectiveness of Pharmacist-Led Intervention for Hepatitis C Patients - A Systematic Review
Pharmacology and Clinical Pharmacy Research · 02.08.2025 · 10 (2)
DOI: 10.15416/pcpr.v10i2.64176 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pharmacology and Clinical Pharmacy Research, online erschienen am 02.08.2025. Verfasst von Geraldo Surya und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pharmacist-led interventions, encompassing patient education, adherence monitoring, and personalized care, have emerged as a critical strategy to optimize treatment outcomes in Hepatitis C (HCV) management, particularly in improving Sustained Virologic Response (SVR) and mitigating drug-related challenges.
Objective
This review assesses the impact of pharmacist-led interventions on key HCV patient outcomes, including SVR rates, medication adherence, and the management of Adverse Drug Reactions (ADRs) and Drug-Drug Interactions (DDIs).
Methods
A systematic search was conducted on PubMed database for studies published between January 2000 and December 2024, following PRISMA guidelines. The search included Randomized Controlled Trials (RCTs), cohort, and retrospective studies. An initial search identified 192 records, from which 12 studies were included in the review.
Result
In hepatitis C management, pharmacists intervened in many ways including direct close monitoring, patient education, and individualized care which led to enhanced clinical outcomes and improved patient engagement. Most included studies, both RCTs and Observational studies showcased high SVR rates. Some studies that demonstrated lower SVR rates or did not differ significantly from the control group were due to more complex patient demographics. Recorded improvements also included medication adherence, patient engagement, and effective management of ADRs and DDIs.
Conclusion
The findings indicate that pharmacist-led interventions demonstrated predominantly positive impacts on clinical outcomes. However, the evidence is limited by variations in study design and shortage of RCTs. Further research with standardized protocols is recommended to better define the role of pharmacists in HCV care.
Zitieren
APA
Surya, G., Angelica, A., Amalia, Z. R., Nisrina, D. K., & Insani, W. N. (2025). Effectiveness of Pharmacist-Led Intervention for Hepatitis C Patients - A Systematic Review. Pharmacology and Clinical Pharmacy Research, 10(2). https://doi.org/10.15416/pcpr.v10i2.64176
Vancouver
Surya G, Angelica A, Amalia ZR, Nisrina DK, Insani WN. Effectiveness of Pharmacist-Led Intervention for Hepatitis C Patients - A Systematic Review. Pharmacology and Clinical Pharmacy Research. 2025;10(2). doi:10.15416/pcpr.v10i2.64176
BibTeX
@article{Surya2025,
author = {Surya, Geraldo and Angelica, Angelica and Amalia, Zerra Rizki and Nisrina, Diflaa Kayla and Insani, Widya Norma},
title = {Effectiveness of Pharmacist-Led Intervention for Hepatitis C Patients - A Systematic Review},
journal = {Pharmacology and Clinical Pharmacy Research},
year = {2025},
volume = {10},
number = {2},
doi = {10.15416/pcpr.v10i2.64176}
}
EUVIMED